The Patent Finder

Engineered ANTI-IL-2 Antibodies

Biolojic Design Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/IB2021/051267, filed Feb 15, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,851,485Engineered ANTI-IL-2 Antibodies
In force
 · High confidence
Biolojic Design Ltd.In force
High confidence
US 12,275,784Engineered ANTI-IL-2 Antibodies
In force
 · High confidence
Biolojic Design Ltd.In force
High confidence
US 12,312,400Engineered ANTI-IL-2 Antibodies
In force
 · High confidence
Biolojic Design Ltd.In force
High confidence
Application 19/075,047Engineered ANTI-IL-2 Antibodies
Pending
Not granted
Biolojic Design Ltd.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Biolojic Design Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited